Deletions of SCN1A 5′ genomic region with promoter activity in Dravet syndrome |
| |
Authors: | Tojo Nakayama Ikuo Ogiwara Koichi Ito Makoto Kaneda Emi Mazaki Hitoshi Osaka Hideyuki Ohtani Yushi Inoue Tateki Fujiwara Mitsugu Uematsu Kazuhiro Haginoya Shigeru Tsuchiya Kazuhiro Yamakawa |
| |
Affiliation: | 1. Laboratory for Neurogenetics, RIKEN Brain Science Institute, Wako, Saitama, Japan;2. Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan;3. Department of Comparative Pathophysiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan;4. Department of Physiology, Keio University School of Medicine, Tokyo, Japan;5. Division of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan;6. National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan |
| |
Abstract: | Mutations involving the voltage‐gated sodium channel αI gene SCN1A are major genetic causes of childhood epileptic disorders, as typified by Dravet syndrome. Here we investigated the upstream regions of the SCN1A 5′ noncoding exons and found two major regions with promoter activity. These two major promoters were simultaneously active in various brain regions and in most neurons. Using multiplex ligation‐dependent probe amplification (MLPA) assays with probes for the 5′ noncoding exons, their upstream regions, and all coding exons of SCN1A, we investigated 130 epileptic patients who did not show any SCN1A mutations by sequence analysis of all coding exons and exon–intron boundaries. Among 71 Dravet syndrome patients, we found two patients with heterozygous microdeletions removing the 5′ noncoding exons and regions with promoter activity but not affecting the coding exons. We also identified four patients with deletions/duplication in the coding region. One patient with symptomatic focal epilepsy also showed a deletion in the coding region. This study provides the first case of microdeletion limited to the SCN1A 5′ promoter region with the coding sequence preserved, and indicates the critical involvement of this upstream region in the molecular pathology of Dravet syndrome. Hum Mutat 31:–11, 2010. © 2010 Wiley‐Liss, Inc. |
| |
Keywords: | SCN1A Dravet syndrome multiplex ligation‐dependent probe amplification assay |
|
|